Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Heptares Therapeutics Raises US$21 Million In Series B Financing 12
Partnerships 13
Heptares Therapeutics Enters into Co-Development Agreement with DyNAbind 13
Heptares Therapeutics Enters into Research Agreement with Imperial College London 14
Heptares Therapeutics Enters into Research Agreement with Juntendo University 15
Heptares Therapeutics and PeptiDream Enter into Agreement 16
Heptares Therapeutics Enters into Research Agreement with New York University School of Medicine 17
Heptares Therapeutics Enters into Research Agreement with University of Cambridge 18
Jitsubo Enters into Agreement with Heptares Therapeutics 19
Heptares Therapeutics and leadXpro Enter into Agreement 20
Heptares Therapeutics to Form Partnership with Kymab 21
Heptares Therapeutics Enters into Agreement with Pfizer 22
MorphoSys Enters into Co-Development Agreement with G7 Therapeutics 23
MorphoSys And Heptares Enter Into Agreement To Develop Antibody Therapeutics Targeting GPCRs 24
Heptares Enters Into Research Agreement With Cubist Pharma For New Medicines Targeting GPCRs 25
Heptares Therapeutics Extends Collaboration with the UK Medical Research 26
ZoBio Enters Into Drug Discovery Agreement With Heptares Therapeutics For Fragment Ligands 27
Licensing Agreements 28
Daiichi Sankyo Enters into Licensing Agreement with Heptares Therapeutics 28
AstraZeneca to Enter into Licensing Agreement with Heptares Therapeutics for HTL-1071 29
Shire Exercises Option To License Adenosine A2A From Heptares Therapeutics 30
Acquisition 31
Heptares Therapeutics Acquires G7 Therapeutics for USD11.8 Million 31
Sosei Acquires Heptares Therapeutics for USD400 Million 32
Heptares Therapeutics Ltd – Key Competitors 33
Heptares Therapeutics Ltd – Key Employees 34
Heptares Therapeutics Ltd – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Government and Public Interest 36
Jan 04, 2018: Heptares Scientists Solve Structure of Complement C5a Receptor, an Important Drug Target for Inflammatory and Neurodegenerative Diseases, and Cancer 36
May 31, 2017: Heptares Solves First Full-length Structure of GLP-1 Receptor Bound to Peptide Agonist 37
Product News 38
May 31, 2017: Sosei Subsidiary Heptares Solves First Full-length Structure of GLP-1 Receptor Bound to Peptide Agonist 38
05/18/2017: Heptares to Receive US$5 Million Milestone Payment from Teva 39
Clinical Trials 40
Apr 05, 2017: Heptares to Receive US$12 Million Milestone Payment from Astrazeneca 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Heptares Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Heptares Therapeutics Raises US$21 Million In Series B Financing 12
Heptares Therapeutics Enters into Co-Development Agreement with DyNAbind 13
Heptares Therapeutics Enters into Research Agreement with Imperial College London 14
Heptares Therapeutics Enters into Research Agreement with Juntendo University 15
Heptares Therapeutics and PeptiDream Enter into Agreement 16
Heptares Therapeutics Enters into Research Agreement with New York University School of Medicine 17
Heptares Therapeutics Enters into Research Agreement with University of Cambridge 18
Jitsubo Enters into Agreement with Heptares Therapeutics 19
Heptares Therapeutics and leadXpro Enter into Agreement 20
Heptares Therapeutics to Form Partnership with Kymab 21
Heptares Therapeutics Enters into Agreement with Pfizer 22
MorphoSys Enters into Co-Development Agreement with G7 Therapeutics 23
MorphoSys And Heptares Enter Into Agreement To Develop Antibody Therapeutics Targeting GPCRs 24
Heptares Enters Into Research Agreement With Cubist Pharma For New Medicines Targeting GPCRs 25
Heptares Therapeutics Extends Collaboration with the UK Medical Research 26
ZoBio Enters Into Drug Discovery Agreement With Heptares Therapeutics For Fragment Ligands 27
Daiichi Sankyo Enters into Licensing Agreement with Heptares Therapeutics 28
AstraZeneca to Enter into Licensing Agreement with Heptares Therapeutics for HTL-1071 29
Shire Exercises Option To License Adenosine A2A From Heptares Therapeutics 30
Heptares Therapeutics Acquires G7 Therapeutics for USD11.8 Million 31
Sosei Acquires Heptares Therapeutics for USD400 Million 32
Heptares Therapeutics Ltd, Key Competitors 33
Heptares Therapeutics Ltd, Key Employees 34
Heptares Therapeutics Ltd, Subsidiaries 35
List of Figures
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Heptares Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9